Live feed
Filing
SC 13G/A
SC 13G/A0000080255-24-000633·Kymera Therapeutics, Inc.
Schedule 13G ownership disclosure
Kymera Therapeutics Inc
Security class unavailable · CUSIP: 501575104
Event date: 2024-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,999,256
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-24-000633
- Form type
- SC 13G/A
- Filer
- Kymera Therapeutics, Inc.
- CIK
- CIK 1815442
- Filed
- Feb 12, 2024
- Reporting period
- Jan 31, 2024
- Description
- Schedule 13G beneficial ownership